{"id":346614,"date":"2025-08-25T10:26:41","date_gmt":"2025-08-25T10:26:41","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-revolution-medicines\/"},"modified":"2025-08-25T10:26:41","modified_gmt":"2025-08-25T10:26:41","slug":"how-to-buy-revolution-medicines","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/","title":{"rendered":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-346614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Revolution Medicines (RVMD) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Revolution Medicines (RVMD) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"Bir sonraki nesil kanser tedavilerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Revolution Medicines (RVMD), bilimin hayat de\u011fi\u015ftiren potansiyelle bulu\u015ftu\u011fu hassas onkolojinin \u00f6n saflar\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki biyoteknoloji \u015firketi, t\u0131bb\u0131n en zorlu sorunlar\u0131ndan baz\u0131lar\u0131yla m\u00fccadele ediyor ve yat\u0131r\u0131mc\u0131lar i\u00e7in bu, volatiliteyle sar\u0131lm\u0131\u015f bir f\u0131rsat anlam\u0131na geliyor. RVMD'nin neden dikkatinizi hak etti\u011fini ve gelecek i\u00e7in kendinizi nas\u0131l konumland\u0131rabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Bir sonraki nesil kanser tedavilerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Revolution Medicines (RVMD), bilimin hayat de\u011fi\u015ftiren potansiyelle bulu\u015ftu\u011fu hassas onkolojinin \u00f6n saflar\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki biyoteknoloji \u015firketi, t\u0131bb\u0131n en zorlu sorunlar\u0131ndan baz\u0131lar\u0131yla m\u00fccadele ediyor ve yat\u0131r\u0131mc\u0131lar i\u00e7in bu, volatiliteyle sar\u0131lm\u0131\u015f bir f\u0131rsat anlam\u0131na geliyor. RVMD'nin neden dikkatinizi hak etti\u011fini ve gelecek i\u00e7in kendinizi nas\u0131l konumland\u0131rabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>Biyoteknoloji \u0130novasyonuna A\u00e7\u0131lan Kap\u0131n\u0131z<\/h2> <p>Bir sonraki nesil kanser tedavilerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Revolution Medicines (RVMD), bilimin hayat de\u011fi\u015ftiren potansiyelle bulu\u015ftu\u011fu hassas onkolojinin \u00f6n saflar\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki biyoteknoloji \u015firketi, t\u0131bb\u0131n en zorlu sorunlar\u0131ndan baz\u0131lar\u0131yla m\u00fccadele ediyor ve yat\u0131r\u0131mc\u0131lar i\u00e7in bu, volatiliteyle sar\u0131lm\u0131\u015f bir f\u0131rsat anlam\u0131na geliyor. RVMD'nin neden dikkatinizi hak etti\u011fini ve gelecek i\u00e7in kendinizi nas\u0131l konumland\u0131rabilece\u011finizi ke\u015ffedelim.<\/p> <p>25 A\u011fustos 2025 itibar\u0131yla, Revolution Medicines (RVMD) hisseleri <strong>37,01 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014hem mevcut sahipler hem de potansiyel yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir d\u00f6neme\u00e7. Bu fiyat noktas\u0131, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 29,17 $'\u0131n %21,2 \u00fczerinde ancak zirvesi olan 62,40 $'\u0131n %68,6 alt\u0131nda bulunuyor ve bir\u00e7ok analistin cazip bir giri\u015f f\u0131rsat\u0131 olarak g\u00f6rd\u00fc\u011f\u00fc bir durum yarat\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcc5 Takviminize Not Edin: 5 Kas\u0131m 2025<\/h2> <p>Bu tarihi k\u0131rm\u0131z\u0131yla i\u015faretleyin: <strong>5 Kas\u0131m 2025<\/strong>. Revolution Medicines'in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn\u2014bu etkinlik genellikle hisse senedinde dramatik hareketlere neden olur.<\/p> <p>Son kazan\u00e7 tepkilerine bakacak olursak:<\/p> <ul> <li><strong>6 A\u011fustos 2025<\/strong>: FDA \u00f6nc\u00fc tedavi tan\u0131mlamalar\u0131na ra\u011fmen hisse %4,5 d\u00fc\u015ft\u00fc<\/li> <li><strong>30 Haziran 2025<\/strong>: Summit Therapeutics ile klinik i\u015f birli\u011fi haberleriyle hisseler %8,2 y\u00fckseldi<\/li> <li><strong>\u015eubat 2025<\/strong>: Pozitif Faz 2 veri a\u00e7\u0131klamalar\u0131n\u0131n ard\u0131ndan %12 art\u0131\u015f<\/li> <li><strong>Kas\u0131m 2024<\/strong>: Kar\u0131\u015f\u0131k deneme sonu\u00e7lar\u0131n\u0131n ard\u0131ndan %18 d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>A\u011fustos 2024<\/strong>: Ortakl\u0131k geni\u015fleme haberleriyle %7 art\u0131\u015f<\/li> <li><strong>May\u0131s 2024<\/strong>: Sa\u011flam preklinik verilere ra\u011fmen dura\u011fan performans<\/li> <\/ul> <p>Bu desen \u00f6nemli bir i\u00e7g\u00f6r\u00fc sunuyor: RVMD, geleneksel finansal metriklerden ziyade klinik deneme g\u00fcncellemelerine dramatik \u015fekilde tepki veriyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar sadece tablolar\u0131 de\u011fil, bilimi takip eder.<\/p> <h2>\ud83d\udcca Alt\u0131 Ayl\u0131k Dalgalanma: \u015eubat-A\u011fustos 2025<\/h2> <p>RVMD'nin son yolculu\u011funu inceleyelim\u2014hi\u00e7 de s\u0131k\u0131c\u0131 olmad\u0131:<\/p> <p><strong>\u015eubat 2025<\/strong>: 42,50 $ - Faz 2 verileri etraf\u0131nda iyimserlik<br\/> <strong>Mart 2025<\/strong>: 38,20 $ - \u0130lk heyecandan sonra kar realizasyonu<br\/> <strong>Nisan 2025<\/strong>: 35,80 $ - Daha geni\u015f biyoteknoloji sekt\u00f6r\u00fcndeki zay\u0131fl\u0131k<br\/> <strong>May\u0131s 2025<\/strong>: 39,40 $ - Pipeline g\u00fcncellemeleriyle toparlanma<br\/> <strong>Haziran 2025<\/strong>: 44,60 $ - Summit Therapeutics i\u015f birli\u011fi deste\u011fi<br\/> <strong>Temmuz 2025<\/strong>: 40,20 $ - Tipik yaz biyoteknoloji durgunlu\u011fu<br\/> <strong>A\u011fustos 2025<\/strong>: 37,01 $ - Kazan\u00e7 sonras\u0131 konsolidasyon<\/p> <p>Hisse bu d\u00f6nemde <strong>%13 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6sterdi, ancak as\u0131l hikaye %25'lik i\u015flem aral\u0131\u011f\u0131\u2014sal\u0131n\u0131m yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in m\u00fckemmel ama uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in sinir bozucu.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: Analist Konsens\u00fcs\u00fc<\/h2> <p>Wall Street b\u00fcy\u00fck bir y\u00fckseli\u015f bekliyor. \u0130\u015fte uzmanlar\u0131n projeksiyonlar\u0131:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 51,45 $ (mevcut seviyelerden %39 art\u0131\u015f)<br\/> <strong>2026 Hedefi<\/strong>: 60-70 $ aral\u0131\u011f\u0131 (%62-%89 potansiyel b\u00fcy\u00fcme)<br\/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 75-85 $ (%100-%130 de\u011fer art\u0131\u015f\u0131)<br\/> <strong>2030 Vizyonu<\/strong>: 90 $+ (%143+ uzun vadeli getiri)<\/p> <p>On \u00fc\u00e7 analist oybirli\u011fiyle RVMD'yi <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RVMD\/forecast\/\">\"G\u00fc\u00e7l\u00fc Al\"<\/a> olarak de\u011ferlendiriyor ve ortalama fiyat hedefi 69,85 $ olarak belirlenmi\u015f durumda. Bu, bug\u00fcnk\u00fc fiyat\u0131n neredeyse iki kat\u0131\u2014ancak unutmay\u0131n, biyoteknoloji tahminleri kesinlikten \u00e7ok umut ta\u015f\u0131r.<\/p> <p><strong>Sonu\u00e7<\/strong>: 3-5 y\u0131ll\u0131k ufku olan risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in ALIM \u00f6nerilir.<\/p> <h2>\u26a0\ufe0f Risk Manzaras\u0131nda Yol Almak<\/h2> <h3>Dikkat Edilmesi Gereken K\u0131rm\u0131z\u0131 Bayraklar<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong> de\u011ferin %50-%70'ini bir gecede silebilir<\/li> <li><strong>Nakit yakma h\u0131zlanmas\u0131<\/strong>\u20142025 2. \u00e7eyrek zarar\u0131 247,8 milyon $ ( <a href=\"https:\/\/www.ainvest.com\/news\/revolution-medicines-rvmd-high-risk-high-reward-biotech-play-ras-oncology-space-2508\/\">y\u0131ll\u0131k %79 art\u0131\u015f<\/a> )<\/li> <li><strong>Gelir s\u0131f\u0131r<\/strong>\u2014bu tamamen gelecekteki ba\u015far\u0131 \u00fczerine spek\u00fclasyondur<\/li> <li><strong>Reg\u00fclasyon engelleri<\/strong>\u2014FDA kararlar\u0131 biyoteknolojileri ya y\u00fckseltir ya da y\u0131kar<\/li> <li><strong>RAS inhibit\u00f6rleri alan\u0131nda artan rekabet<\/strong><\/li> <\/ul> <h3>Parlayan Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Royalty Pharma anla\u015fmas\u0131ndan 2,1 milyar $ nakit<\/strong> ( <a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">Haziran 2025'te g\u00fcvence alt\u0131na al\u0131nd\u0131<\/a> )<\/li> <li><strong>\u0130ki program i\u00e7in FDA \u00d6ncelikli Tedavi Tan\u0131m\u0131<\/strong><\/li> <li><strong>Faz 3 denemeleri ilerliyor<\/strong>, tamamlanmas\u0131 2025 sonu bekleniyor<\/li> <li><strong>T\u00fcm analistlerin \"Al\" konsens\u00fcs\u00fc<\/strong>\u2014Wall Street'te nadir bir oybirli\u011fi<\/li> <li><strong>Y\u0131ll\u0131k 10 milyar $'\u0131 a\u015fan RAS pazar potansiyeli<\/strong><\/li> <\/ul> <h2>\ud83c\udfaf Yeni Ba\u015flayanlar i\u00e7in Eylem Plan\u0131<\/h2> <p>Bug\u00fcn ne yapmal\u0131s\u0131n\u0131z? \u0130\u015fte a\u00e7\u0131k s\u00f6zl\u00fcl\u00fc\u011f\u00fcm:<\/p> <ol> <li><strong>Ak\u0131ll\u0131ca tahsis edin<\/strong>\u2014Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 tek bir biyotek hisse senedine koymay\u0131n<\/li> <li><strong>Dolar-maliyet ortalamas\u0131 yap\u0131n<\/strong>\u2014Birka\u00e7 ay boyunca 500-1000 $ aras\u0131 par\u00e7alarla sat\u0131n al\u0131n<\/li> <li><strong>Zihinsel stop-loss belirleyin<\/strong>\u201432 $ alt\u0131na d\u00fc\u015ferse \u00e7\u0131kmaya haz\u0131r olun<\/li> <li><strong>Bilimi takip edin<\/strong>\u2014Kazan\u00e7 raporlar\u0131ndan \u00e7ok klinik deneme duyurular\u0131n\u0131 izleyin<\/li> <li><strong>Mizah molas\u0131<\/strong>: \"RVMD ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici at\u0131l\u0131mlar ve ara s\u0131ra laboratuvar patlamalar\u0131. Koruyucu g\u00f6zl\u00fcklerinizi takmay\u0131 unutmay\u0131n!\"<\/li> <\/ol> <h2>\u2705 Sahiplik \u0130\u00e7in Ad\u0131m Ad\u0131m Yol Haritan\u0131z<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Platformunuzu se\u00e7in<\/td><td>NASDAQ listeleri ve par\u00e7al\u0131 hisse sunan bir platform oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td><td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"RVMD\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>36,50-37,50 $ civar\u0131nda L\u0130M\u0130T emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin\u2014%1'in alt\u0131nda hedefleyin<\/td><\/tr> <tr><td>6<\/td><td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td><td>32 $ (a\u015fa\u011f\u0131 y\u00f6n) ve 45 $ (yukar\u0131 y\u00f6n) i\u00e7in bildirimler<\/td><\/tr> <tr><td>7<\/td><td>Tezinizi belgeleyin<\/td><td>Neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n\u2014duygusal sat\u0131\u015flar\u0131 \u00f6nler<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option RVMD Ticareti \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2> <p>Geleneksel brokerlar uzun vadeli tutma i\u00e7in uygundur, ancak <a href=\"https:\/\/pocketoption.com\">Pocket Option<\/a>, biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong>\u2014emeklilik fonunuzu riske atmadan ger\u00e7ek parayla stratejileri test edin<\/li> <li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda i\u015flem<\/strong>\u2014biyoteknoloji haberlerindeki ani y\u00fckseli\u015fleri yakalamak i\u00e7in kritik<\/li> <li><strong>Geli\u015fmi\u015f grafik ara\u00e7lar\u0131<\/strong>\u2014RVMD'nin volatil desenlerini analiz etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong>\u2014denemeler ba\u015far\u0131l\u0131 oldu\u011funda kazan\u00e7lar\u0131n\u0131z\u0131 h\u0131zl\u0131ca al\u0131n<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, biyoteknoloji sekt\u00f6r\u00fcn\u00fcn ritmini \u00f6\u011frenirken pozisyonunuzu kademeli olarak olu\u015fturmak i\u00e7in idealdir.<\/p> <h2>\ud83e\uddec 2025'te Revolution Medicines: RAS \u00d6nc\u00fcs\u00fc<\/h2> <p>Bug\u00fcn Revolution Medicines, insan kanserlerinin yakla\u015f\u0131k %30'unu tetikleyen RAS mutasyonlar\u0131n\u0131 hedefleyen onkolojinin en heyecan verici alanlar\u0131ndan birinin \u00f6nc\u00fcs\u00fcd\u00fcr. \u015eirketin <a href=\"https:\/\/www.globaldata.com\/company-profile\/revolution-medicines-inc\/\">hassas yakla\u015f\u0131m\u0131<\/a>, daha \u00f6nce \"ila\u00e7 geli\u015ftirilemez\" olarak kabul edilen hedeflere odaklanmakta olup, ba\u015f aday daraxonrasib pankreas ve akci\u011fer kanserlerinde umut vaat etmektedir.<\/p> <p>\u015eirketin 2,1 milyar $ nakit pozisyonu\u2014o parlak <a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">Royalty Pharma anla\u015fmas\u0131<\/a> ile g\u00fc\u00e7lendirilmi\u015f\u20142027 y\u0131l\u0131na kadar finansal dayan\u0131kl\u0131l\u0131k sa\u011flamakta ve k\u0131sa vadeli seyrelme riskini azaltmaktad\u0131r. Faz 3 verilerinin yak\u0131nda gelmesi ve \u00d6ncelikli Tedavi Tan\u0131m\u0131 ile RVMD, potansiyel olarak uygulamay\u0131 de\u011fi\u015ftirecek duyurulara aylar uzakl\u0131kta olabilir.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025 y\u0131l\u0131nda Revolution Medicines ara\u015ft\u0131rma ekibi, ba\u015f bile\u015fiklerinin sadece kanser b\u00fcy\u00fcmesini engellemekle kalmay\u0131p t\u00fcm\u00f6r mikro\u00e7evresini yeniden programlad\u0131\u011f\u0131n\u0131 ke\u015ffetti\u2014bu \u00e7ift mekanizma, erken etkinlik verilerinin ola\u011fan\u00fcst\u00fc olmas\u0131n\u0131 a\u00e7\u0131klayabilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Biyoteknoloji \u0130novasyonuna A\u00e7\u0131lan Kap\u0131n\u0131z<\/h2>\n<p>Bir sonraki nesil kanser tedavilerine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Revolution Medicines (RVMD), bilimin hayat de\u011fi\u015ftiren potansiyelle bulu\u015ftu\u011fu hassas onkolojinin \u00f6n saflar\u0131n\u0131 temsil ediyor. Bu klinik a\u015famadaki biyoteknoloji \u015firketi, t\u0131bb\u0131n en zorlu sorunlar\u0131ndan baz\u0131lar\u0131yla m\u00fccadele ediyor ve yat\u0131r\u0131mc\u0131lar i\u00e7in bu, volatiliteyle sar\u0131lm\u0131\u015f bir f\u0131rsat anlam\u0131na geliyor. RVMD&#8217;nin neden dikkatinizi hak etti\u011fini ve gelecek i\u00e7in kendinizi nas\u0131l konumland\u0131rabilece\u011finizi ke\u015ffedelim.<\/p>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Revolution Medicines (RVMD) hisseleri <strong>37,01 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014hem mevcut sahipler hem de potansiyel yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir d\u00f6neme\u00e7. Bu fiyat noktas\u0131, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 29,17 $&#8217;\u0131n %21,2 \u00fczerinde ancak zirvesi olan 62,40 $&#8217;\u0131n %68,6 alt\u0131nda bulunuyor ve bir\u00e7ok analistin cazip bir giri\u015f f\u0131rsat\u0131 olarak g\u00f6rd\u00fc\u011f\u00fc bir durum yarat\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcc5 Takviminize Not Edin: 5 Kas\u0131m 2025<\/h2>\n<p>Bu tarihi k\u0131rm\u0131z\u0131yla i\u015faretleyin: <strong>5 Kas\u0131m 2025<\/strong>. Revolution Medicines&#8217;in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn\u2014bu etkinlik genellikle hisse senedinde dramatik hareketlere neden olur.<\/p>\n<p>Son kazan\u00e7 tepkilerine bakacak olursak:<\/p>\n<ul>\n<li><strong>6 A\u011fustos 2025<\/strong>: FDA \u00f6nc\u00fc tedavi tan\u0131mlamalar\u0131na ra\u011fmen hisse %4,5 d\u00fc\u015ft\u00fc<\/li>\n<li><strong>30 Haziran 2025<\/strong>: Summit Therapeutics ile klinik i\u015f birli\u011fi haberleriyle hisseler %8,2 y\u00fckseldi<\/li>\n<li><strong>\u015eubat 2025<\/strong>: Pozitif Faz 2 veri a\u00e7\u0131klamalar\u0131n\u0131n ard\u0131ndan %12 art\u0131\u015f<\/li>\n<li><strong>Kas\u0131m 2024<\/strong>: Kar\u0131\u015f\u0131k deneme sonu\u00e7lar\u0131n\u0131n ard\u0131ndan %18 d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>A\u011fustos 2024<\/strong>: Ortakl\u0131k geni\u015fleme haberleriyle %7 art\u0131\u015f<\/li>\n<li><strong>May\u0131s 2024<\/strong>: Sa\u011flam preklinik verilere ra\u011fmen dura\u011fan performans<\/li>\n<\/ul>\n<p>Bu desen \u00f6nemli bir i\u00e7g\u00f6r\u00fc sunuyor: RVMD, geleneksel finansal metriklerden ziyade klinik deneme g\u00fcncellemelerine dramatik \u015fekilde tepki veriyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar sadece tablolar\u0131 de\u011fil, bilimi takip eder.<\/p>\n<h2>\ud83d\udcca Alt\u0131 Ayl\u0131k Dalgalanma: \u015eubat-A\u011fustos 2025<\/h2>\n<p>RVMD&#8217;nin son yolculu\u011funu inceleyelim\u2014hi\u00e7 de s\u0131k\u0131c\u0131 olmad\u0131:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 42,50 $ &#8211; Faz 2 verileri etraf\u0131nda iyimserlik<br \/> <strong>Mart 2025<\/strong>: 38,20 $ &#8211; \u0130lk heyecandan sonra kar realizasyonu<br \/> <strong>Nisan 2025<\/strong>: 35,80 $ &#8211; Daha geni\u015f biyoteknoloji sekt\u00f6r\u00fcndeki zay\u0131fl\u0131k<br \/> <strong>May\u0131s 2025<\/strong>: 39,40 $ &#8211; Pipeline g\u00fcncellemeleriyle toparlanma<br \/> <strong>Haziran 2025<\/strong>: 44,60 $ &#8211; Summit Therapeutics i\u015f birli\u011fi deste\u011fi<br \/> <strong>Temmuz 2025<\/strong>: 40,20 $ &#8211; Tipik yaz biyoteknoloji durgunlu\u011fu<br \/> <strong>A\u011fustos 2025<\/strong>: 37,01 $ &#8211; Kazan\u00e7 sonras\u0131 konsolidasyon<\/p>\n<p>Hisse bu d\u00f6nemde <strong>%13 d\u00fc\u015f\u00fc\u015f<\/strong> g\u00f6sterdi, ancak as\u0131l hikaye %25&#8217;lik i\u015flem aral\u0131\u011f\u0131\u2014sal\u0131n\u0131m yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in m\u00fckemmel ama uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in sinir bozucu.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: Analist Konsens\u00fcs\u00fc<\/h2>\n<p>Wall Street b\u00fcy\u00fck bir y\u00fckseli\u015f bekliyor. \u0130\u015fte uzmanlar\u0131n projeksiyonlar\u0131:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 51,45 $ (mevcut seviyelerden %39 art\u0131\u015f)<br \/> <strong>2026 Hedefi<\/strong>: 60-70 $ aral\u0131\u011f\u0131 (%62-%89 potansiyel b\u00fcy\u00fcme)<br \/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 75-85 $ (%100-%130 de\u011fer art\u0131\u015f\u0131)<br \/> <strong>2030 Vizyonu<\/strong>: 90 $+ (%143+ uzun vadeli getiri)<\/p>\n<p>On \u00fc\u00e7 analist oybirli\u011fiyle RVMD&#8217;yi <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/RVMD\/forecast\/\">&#8220;G\u00fc\u00e7l\u00fc Al&#8221;<\/a> olarak de\u011ferlendiriyor ve ortalama fiyat hedefi 69,85 $ olarak belirlenmi\u015f durumda. Bu, bug\u00fcnk\u00fc fiyat\u0131n neredeyse iki kat\u0131\u2014ancak unutmay\u0131n, biyoteknoloji tahminleri kesinlikten \u00e7ok umut ta\u015f\u0131r.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: 3-5 y\u0131ll\u0131k ufku olan risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in ALIM \u00f6nerilir.<\/p>\n<h2>\u26a0\ufe0f Risk Manzaras\u0131nda Yol Almak<\/h2>\n<h3>Dikkat Edilmesi Gereken K\u0131rm\u0131z\u0131 Bayraklar<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong> de\u011ferin %50-%70&#8217;ini bir gecede silebilir<\/li>\n<li><strong>Nakit yakma h\u0131zlanmas\u0131<\/strong>\u20142025 2. \u00e7eyrek zarar\u0131 247,8 milyon $ ( <a href=\"https:\/\/www.ainvest.com\/news\/revolution-medicines-rvmd-high-risk-high-reward-biotech-play-ras-oncology-space-2508\/\">y\u0131ll\u0131k %79 art\u0131\u015f<\/a> )<\/li>\n<li><strong>Gelir s\u0131f\u0131r<\/strong>\u2014bu tamamen gelecekteki ba\u015far\u0131 \u00fczerine spek\u00fclasyondur<\/li>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>\u2014FDA kararlar\u0131 biyoteknolojileri ya y\u00fckseltir ya da y\u0131kar<\/li>\n<li><strong>RAS inhibit\u00f6rleri alan\u0131nda artan rekabet<\/strong><\/li>\n<\/ul>\n<h3>Parlayan Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Royalty Pharma anla\u015fmas\u0131ndan 2,1 milyar $ nakit<\/strong> ( <a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">Haziran 2025&#8217;te g\u00fcvence alt\u0131na al\u0131nd\u0131<\/a> )<\/li>\n<li><strong>\u0130ki program i\u00e7in FDA \u00d6ncelikli Tedavi Tan\u0131m\u0131<\/strong><\/li>\n<li><strong>Faz 3 denemeleri ilerliyor<\/strong>, tamamlanmas\u0131 2025 sonu bekleniyor<\/li>\n<li><strong>T\u00fcm analistlerin &#8220;Al&#8221; konsens\u00fcs\u00fc<\/strong>\u2014Wall Street&#8217;te nadir bir oybirli\u011fi<\/li>\n<li><strong>Y\u0131ll\u0131k 10 milyar $&#8217;\u0131 a\u015fan RAS pazar potansiyeli<\/strong><\/li>\n<\/ul>\n<h2>\ud83c\udfaf Yeni Ba\u015flayanlar i\u00e7in Eylem Plan\u0131<\/h2>\n<p>Bug\u00fcn ne yapmal\u0131s\u0131n\u0131z? \u0130\u015fte a\u00e7\u0131k s\u00f6zl\u00fcl\u00fc\u011f\u00fcm:<\/p>\n<ol>\n<li><strong>Ak\u0131ll\u0131ca tahsis edin<\/strong>\u2014Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 tek bir biyotek hisse senedine koymay\u0131n<\/li>\n<li><strong>Dolar-maliyet ortalamas\u0131 yap\u0131n<\/strong>\u2014Birka\u00e7 ay boyunca 500-1000 $ aras\u0131 par\u00e7alarla sat\u0131n al\u0131n<\/li>\n<li><strong>Zihinsel stop-loss belirleyin<\/strong>\u201432 $ alt\u0131na d\u00fc\u015ferse \u00e7\u0131kmaya haz\u0131r olun<\/li>\n<li><strong>Bilimi takip edin<\/strong>\u2014Kazan\u00e7 raporlar\u0131ndan \u00e7ok klinik deneme duyurular\u0131n\u0131 izleyin<\/li>\n<li><strong>Mizah molas\u0131<\/strong>: &#8220;RVMD ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici at\u0131l\u0131mlar ve ara s\u0131ra laboratuvar patlamalar\u0131. Koruyucu g\u00f6zl\u00fcklerinizi takmay\u0131 unutmay\u0131n!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Sahiplik \u0130\u00e7in Ad\u0131m Ad\u0131m Yol Haritan\u0131z<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve par\u00e7al\u0131 hisse sunan bir platform oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td>\n<td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;RVMD&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>36,50-37,50 $ civar\u0131nda L\u0130M\u0130T emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014%1&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td>\n<td>32 $ (a\u015fa\u011f\u0131 y\u00f6n) ve 45 $ (yukar\u0131 y\u00f6n) i\u00e7in bildirimler<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Tezinizi belgeleyin<\/td>\n<td>Neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n\u2014duygusal sat\u0131\u015flar\u0131 \u00f6nler<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option RVMD Ticareti \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2>\n<p>Geleneksel brokerlar uzun vadeli tutma i\u00e7in uygundur, ancak <a href=\"https:\/\/pocketoption.com\">Pocket Option<\/a>, biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong>\u2014emeklilik fonunuzu riske atmadan ger\u00e7ek parayla stratejileri test edin<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda i\u015flem<\/strong>\u2014biyoteknoloji haberlerindeki ani y\u00fckseli\u015fleri yakalamak i\u00e7in kritik<\/li>\n<li><strong>Geli\u015fmi\u015f grafik ara\u00e7lar\u0131<\/strong>\u2014RVMD&#8217;nin volatil desenlerini analiz etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong>\u2014denemeler ba\u015far\u0131l\u0131 oldu\u011funda kazan\u00e7lar\u0131n\u0131z\u0131 h\u0131zl\u0131ca al\u0131n<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, biyoteknoloji sekt\u00f6r\u00fcn\u00fcn ritmini \u00f6\u011frenirken pozisyonunuzu kademeli olarak olu\u015fturmak i\u00e7in idealdir.<\/p>\n<h2>\ud83e\uddec 2025&#8217;te Revolution Medicines: RAS \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Bug\u00fcn Revolution Medicines, insan kanserlerinin yakla\u015f\u0131k %30&#8217;unu tetikleyen RAS mutasyonlar\u0131n\u0131 hedefleyen onkolojinin en heyecan verici alanlar\u0131ndan birinin \u00f6nc\u00fcs\u00fcd\u00fcr. \u015eirketin <a href=\"https:\/\/www.globaldata.com\/company-profile\/revolution-medicines-inc\/\">hassas yakla\u015f\u0131m\u0131<\/a>, daha \u00f6nce &#8220;ila\u00e7 geli\u015ftirilemez&#8221; olarak kabul edilen hedeflere odaklanmakta olup, ba\u015f aday daraxonrasib pankreas ve akci\u011fer kanserlerinde umut vaat etmektedir.<\/p>\n<p>\u015eirketin 2,1 milyar $ nakit pozisyonu\u2014o parlak <a href=\"https:\/\/www.royaltypharma.com\/news\/royalty-pharma-and-revolution-medicines-enter-into-funding-agreements-for-up-to-2-billion\/\">Royalty Pharma anla\u015fmas\u0131<\/a> ile g\u00fc\u00e7lendirilmi\u015f\u20142027 y\u0131l\u0131na kadar finansal dayan\u0131kl\u0131l\u0131k sa\u011flamakta ve k\u0131sa vadeli seyrelme riskini azaltmaktad\u0131r. Faz 3 verilerinin yak\u0131nda gelmesi ve \u00d6ncelikli Tedavi Tan\u0131m\u0131 ile RVMD, potansiyel olarak uygulamay\u0131 de\u011fi\u015ftirecek duyurulara aylar uzakl\u0131kta olabilir.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025 y\u0131l\u0131nda Revolution Medicines ara\u015ft\u0131rma ekibi, ba\u015f bile\u015fiklerinin sadece kanser b\u00fcy\u00fcmesini engellemekle kalmay\u0131p t\u00fcm\u00f6r mikro\u00e7evresini yeniden programlad\u0131\u011f\u0131n\u0131 ke\u015ffetti\u2014bu \u00e7ift mekanizma, erken etkinlik verilerinin ola\u011fan\u00fcst\u00fc olmas\u0131n\u0131 a\u00e7\u0131klayabilir.<\/p>\n"},"faq":[{"question":"Revolution Medicines (RVMD) hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"RVMD hisselerini sat\u0131n almak i\u00e7in NASDAQ listesi sunan bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"RVMD\" sembol\u00fc ile arama yap\u0131n, uygun emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n."},{"question":"RVMD hisseleri i\u00e7in riskler nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, nakit yakma h\u0131zlanmas\u0131, gelir olmamas\u0131, reg\u00fclasyon engelleri ve artan rekabet RVMD hisseleri i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"RVMD hisseleri i\u00e7in fiyat tahminleri nelerdir?","answer":"Analistler 2025 sonunda 51,45 $, 2026'da 60-70 $, 2028'de 75-85 $ ve 2030'da 90 $+ fiyat hedeflemektedir."},{"question":"RVMD hisseleri i\u00e7in yat\u0131r\u0131m stratejisi nedir?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 yat\u0131rmay\u0131n, dolar-maliyet ortalamas\u0131 yap\u0131n, zihinsel stop-loss belirleyin ve klinik deneme haberlerini yak\u0131ndan takip edin."},{"question":"Pocket Option RVMD ticareti i\u00e7in neden \u00f6nerilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 i\u015flem h\u0131z\u0131, geli\u015fmi\u015f grafik ara\u00e7lar\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile Pocket Option, biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in avantajlar sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Revolution Medicines (RVMD) hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"RVMD hisselerini sat\u0131n almak i\u00e7in NASDAQ listesi sunan bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"RVMD\" sembol\u00fc ile arama yap\u0131n, uygun emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylay\u0131n."},{"question":"RVMD hisseleri i\u00e7in riskler nelerdir?","answer":"Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, nakit yakma h\u0131zlanmas\u0131, gelir olmamas\u0131, reg\u00fclasyon engelleri ve artan rekabet RVMD hisseleri i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"RVMD hisseleri i\u00e7in fiyat tahminleri nelerdir?","answer":"Analistler 2025 sonunda 51,45 $, 2026'da 60-70 $, 2028'de 75-85 $ ve 2030'da 90 $+ fiyat hedeflemektedir."},{"question":"RVMD hisseleri i\u00e7in yat\u0131r\u0131m stratejisi nedir?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 yat\u0131rmay\u0131n, dolar-maliyet ortalamas\u0131 yap\u0131n, zihinsel stop-loss belirleyin ve klinik deneme haberlerini yak\u0131ndan takip edin."},{"question":"Pocket Option RVMD ticareti i\u00e7in neden \u00f6nerilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 i\u015flem h\u0131z\u0131, geli\u015fmi\u015f grafik ara\u00e7lar\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile Pocket Option, biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in avantajlar sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T10:26:41+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T10:26:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\",\"name\":\"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-25T10:26:41+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/","og_locale":"tr_TR","og_type":"article","og_title":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T10:26:41+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T10:26:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/","name":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r - Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-25T10:26:41+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-revolution-medicines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Revolution Medicines, Inc. (RVMD) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Revolution Medicines, Inc. (RVMD) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":346615,"slug":"how-to-buy-revolution-medicines","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Revolution Medicines, Inc. (RVMD) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-revolution-medicines\/"},"pt_AA":{"locale":"pt_AA","id":346612,"slug":"how-to-buy-revolution-medicines","post_title":"Como comprar a\u00e7\u00f5es da Revolution Medicines, Inc. (RVMD) - Investimento em a\u00e7\u00f5es da Revolution Medicines, Inc. (RVMD)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-revolution-medicines\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/346614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=346614"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/346614\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=346614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=346614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=346614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}